LGALS3 and chronic kidney disease: An increase in the concentration of galectin-3 is associated with kidney fibrosis, increased risks of rapid renal function decline, incident chronic kidney disease, and progressive renal impairment, as well as cardiovascular endpoints, infection, and all-cause mortality in patients with renal failure [92].